WallStreetZenWallStreetZen

NYSE: CNVY
Convey Health Solutions Holdings Inc Stock Forecast, Predictions & Price Target

Open Broker Account

Analyst price target for CNVY

Based on 3 analysts offering 12 month price targets for Convey Health Solutions Holdings Inc.
Min Forecast
$8.00-23.95%
Avg Forecast
$11.00+4.56%
Max Forecast
$14.00+33.08%

Should I buy or sell CNVY stock?

Based on 4 analysts offering ratings for Convey Health Solutions Holdings Inc.
Buy
Strong Buy
1 analysts 25%
Buy
0 analysts 0%
Hold
3 analysts 75%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their CNVY stock forecasts and price targets.

CNVY stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
Guggenheim
Top 5%
96
HoldDowngradesN/AN/A2022-06-22
Barclays
Bottom 18%
18
HoldDowngrades$11.00+4.56%2022-06-22
Goldman Sachs
Bottom 23%
23
HoldMaintains$8.00-23.95%2022-05-12
Canaccord Genuity
Bottom 12%
12
Strong BuyMaintains$14.00+33.08%2022-03-24

1 of 1

Forecast return on equity

Is CNVY forecast to generate an efficient return?
Company
N/A
Industry
12.01%
Market
121.65%

Forecast return on assets

Is CNVY forecast to generate an efficient return on assets?
Company
N/A
Industry
8.25%

CNVY earnings per share forecast

What is CNVY's earnings per share in the next 2 years based on estimates from 1 analyst?
Avg 1 year Forecast
$0.29
Avg 2 year Forecast
$0.41

CNVY revenue forecast

What is CNVY's revenue in the next 3 years based on estimates from 1 analyst?
Avg 1 year Forecast
$398.8M+8.9%
Avg 2 year Forecast
$460.0M+25.6%
Avg 3 year Forecast
$501.0M+36.81%
CNVY's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

CNVY revenue growth forecast

How is CNVY forecast to perform vs Health Information Services companies and vs the US market?
Company
11.01%
Industry
14.79%
Market
8.48%
CNVY's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
CNVY's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

CNVY vs Health Information Service Stocks

TickerPricePrice TargetUp/downsideConsensus
CNVY$10.52$11.00+4.56%Buy
SHCR$1.90$4.87+156.16%Buy
CMAX$7.60$11.25+48.03%Buy
HSTM$21.30$24.00+12.68%Buy
ACCD$12.52$16.61+32.64%Buy

Convey Health Solutions Holdings Stock Forecast FAQ

Is Convey Health Solutions Holdings Stock a good buy in 2022, according to Wall Street analysts?

The consensus among 4 Wall Street analysts covering (NYSE: CNVY) stock is to Buy CNVY stock.

Out of 4 analysts, 1 (25%) are recommending CNVY as a Strong Buy, 0 (0%) are recommending CNVY as a Buy, 3 (75%) are recommending CNVY as a Hold, 0 (0%) are recommending CNVY as a Sell, and 0 (0%) are recommending CNVY as a Strong Sell.

If you're new to stock investing, here's how to buy Convey Health Solutions Holdings stock.

What is CNVY's earnings growth forecast for 2022-2023?

(NYSE: CNVY) Convey Health Solutions Holdings's forecast annual earnings growth rate of N/A is not forecast to beat the US Health Information Services industry's average forecast earnings growth rate of 7.91%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 16.67%.

Convey Health Solutions Holdings's earnings in 2022 is -$6,945,000.On average, 1 Wall Street analyst forecast CNVY's earnings for 2022 to be $21,234,270, with the lowest CNVY earnings forecast at $21,234,270, and the highest CNVY earnings forecast at $21,234,270.

In 2023, CNVY is forecast to generate $30,020,865 in earnings, with the lowest earnings forecast at $27,824,216 and the highest earnings forecast at $32,217,514.

What is CNVY's revenue growth forecast for 2022-2024?

(NYSE: CNVY) Convey Health Solutions Holdings's forecast annual revenue growth rate of 11.01% is not forecast to beat the US Health Information Services industry's average forecast revenue growth rate of 14.79%, and while it is forecast to beat the US market's average forecast revenue growth rate of 8.48%.

Convey Health Solutions Holdings's revenue in 2022 is $366,207,000.On average, 1 Wall Street analysts forecast CNVY's revenue for 2022 to be $29,200,782,854, with the lowest CNVY revenue forecast at $29,200,782,854, and the highest CNVY revenue forecast at $29,200,782,854. On average, 1 Wall Street analysts forecast CNVY's revenue for 2023 to be $33,679,749,471, with the lowest CNVY revenue forecast at $33,679,749,471, and the highest CNVY revenue forecast at $33,679,749,471.

In 2024, CNVY is forecast to generate $36,684,032,622 in revenue, with the lowest revenue forecast at $36,684,032,622 and the highest revenue forecast at $36,684,032,622.

What is CNVY's forecast return on assets (ROA) for 2022-2025?

(NYSE: CNVY) forecast ROA is N/A, which is lower than the forecast US Health Information Services industry average of 8.25%.

What is CNVY's Price Target?

According to 3 Wall Street analysts that have issued a 1 year CNVY price target, the average CNVY price target is $11.00, with the highest CNVY stock price forecast at $14.00 and the lowest CNVY stock price forecast at $8.00.

On average, Wall Street analysts predict that Convey Health Solutions Holdings's share price could reach $11.00 by Jun 22, 2023. The average Convey Health Solutions Holdings stock price prediction forecasts a potential upside of 4.56% from the current CNVY share price of $10.52.

What is CNVY's Earnings Per Share (EPS) forecast for 2022-2023?

(NYSE: CNVY) Convey Health Solutions Holdings's current Earnings Per Share (EPS) is -$0.10. On average, analysts forecast that CNVY's EPS will be $0.29 for 2022, with the lowest EPS forecast at $0.29, and the highest EPS forecast at $0.29. In 2023, CNVY's EPS is forecast to hit $0.41 (min: $0.38, max: $0.44).

What is CNVY's forecast return on equity (ROE) for 2022-2025?

(NYSE: CNVY) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.